{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:10:33Z","timestamp":1778458233284,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02895-5","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:47:16Z","timestamp":1774925236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of the atherogenic index of plasma in patients with multivessel coronary disease undergoing CABG: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-qun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-fei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-bo","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"20","key":"2895_CR1","doi-asserted-by":"publisher","first-page":"e029397","DOI":"10.1161\/JAHA.123.029397","volume":"12","author":"L Tang","year":"2023","unstructured":"Tang L, Chen H, Hu X, Fang Z, Liao X, Zhou X, Yang H, Tu T, Zhu Z, Zhou S, et al. Intensive lipid-lowering therapy as per the latest dyslipidemia management guideline in predicting favorable long-term clinical outcomes in patients undergoing coronary artery bypass grafting: a retrospective cohort study. J Am Heart Assoc. 2023;12(20):e029397.","journal-title":"J AM HEART ASSOC"},{"issue":"14","key":"2895_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/CIRCULATIONAHA.116.022572","volume":"136","author":"SJ Head","year":"2017","unstructured":"Head SJ, Milojevic M, Taggart DP, Puskas JD. Current practice of state-of-the-art surgical coronary revascularization. Circulation. 2017;136(14):1331\u201345.","journal-title":"Circulation"},{"issue":"20","key":"2895_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.jacc.2007.12.054","volume":"51","author":"SJ Shah","year":"2008","unstructured":"Shah SJ, Waters DD, Barter P, Kastelein JJP, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol. 2008;51(20):1938\u201343.","journal-title":"J AM COLL CARDIOL"},{"issue":"9","key":"2895_CR4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jacc.2019.07.015","volume":"74","author":"SG Goodman","year":"2019","unstructured":"Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, et al. Effects of alirocumab on cardiovascular events after coronary bypass surgery. J Am Coll Cardiol. 2019;74(9):1177\u201386.","journal-title":"J AM COLL CARDIOL"},{"issue":"7324","key":"2895_CR5","first-page":"3168","volume":"2019","author":"SM Grundy","year":"2018","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, et al. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;2019(7324):3168\u2013209.","journal-title":"J AM COLL CARDIOL"},{"issue":"1","key":"2895_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"EUR HEART J"},{"issue":"15","key":"2895_CR7","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2018.2525","volume":"319","author":"EP Navarese","year":"2018","unstructured":"Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. Jama-J Am Med Assoc. 2018;319(15):1566\u201379.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"1 Suppl","key":"2895_CR8","first-page":"I454","volume":"114","author":"JFR Sabik","year":"2006","unstructured":"Sabik JFR, Blackstone EH, Gillinov AM, Smedira NG, Lytle BW. Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation. 2006;114(1 Suppl):I454\u201360.","journal-title":"Circulation"},{"issue":"1","key":"2895_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tcm.2012.08.004","volume":"23","author":"A Polimeni","year":"2013","unstructured":"Polimeni A, De Rosa S, Indolfi C. Vascular MiRNAs after balloon angioplasty. Trends Cardiovas Med. 2013;23(1):9\u201314.","journal-title":"TRENDS CARDIOVAS MED"},{"issue":"2","key":"2895_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.12997\/jla.2022.11.2.187","volume":"11","author":"NSR Lan","year":"2022","unstructured":"Lan NSR, Ali US, Yeap BB, Fegan PG, Larbalestier R, Bell DA. Attainment of lipid targets following coronary artery bypass graft surgery: can we do better? J Lipid Atheroscler. 2022;11(2):187\u201396.","journal-title":"J Lipid Atheroscler"},{"key":"2895_CR11","first-page":"240","volume":"29","author":"S Niroumand","year":"2015","unstructured":"Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, Dadgarmoghaddam M. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.","journal-title":"Med J Islam Repub Iran"},{"key":"2895_CR12","doi-asserted-by":"publisher","first-page":"817441","DOI":"10.3389\/fcvm.2021.817441","volume":"8","author":"J Wu","year":"2021","unstructured":"Wu J, Zhou Q, Wei Z, Wei J, Cui M. Atherogenic index of plasma and coronary artery disease in the adult population: a meta-analysis. Front Cardiovasc Med. 2021;8:817441.","journal-title":"FRONT CARDIOVASC MED"},{"issue":"SupplSuppl","key":"2895_CR13","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1194\/jlr.R800034-JLR200","volume":"50","author":"K Rye","year":"2009","unstructured":"Rye K, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res. 2009;50(SupplSuppl):S195\u2013200.","journal-title":"J LIPID RES"},{"issue":"5","key":"2895_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"ARCH MED RES"},{"issue":"1","key":"2895_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, Song X, Xiong Z, Deng L, Li D, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254.","journal-title":"CARDIOVASC DIABETOL"},{"issue":"1","key":"2895_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-023-01888-3","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang S, Sun S, Li F, Zhao W, Yang H, Wu X. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol\/L. Cardiovasc Diabetol. 2023;22(1):150.","journal-title":"CARDIOVASC DIABETOL"},{"issue":"2","key":"2895_CR17","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(2):e21\u2013129.","journal-title":"J AM COLL CARDIOL"},{"issue":"1","key":"2895_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jtcvs.2017.06.039","volume":"155","author":"A Hage","year":"2018","unstructured":"Hage A, Voisine P, Erthal F, Larose \u00c9, Glineur D, Chow B, Tremblay H, Fortier J, Ko G, Une D, et al. Eight-year follow-up of the clopidogrel after surgery for coronary artery disease (CASCADE) trial. J Thorac Cardiov Sur. 2018;155(1):212\u201322.","journal-title":"J THORAC CARDIOV SUR"},{"issue":"9","key":"2895_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.120.052163","volume":"144","author":"I Xenogiannis","year":"2021","unstructured":"Xenogiannis I, Zenati M, Bhatt DL, Rao SV, Rod\u00e9s-Cabau J, Goldman S, Shunk KA, Mavromatis K, Banerjee S, Alaswad K, et al. Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies. Circulation. 2021;144(9):728\u201345.","journal-title":"Circulation"},{"key":"2895_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2020.03.013","volume":"300","author":"J Stock","year":"2020","unstructured":"Stock J. Targeting LDL cholesterol: early treatment is key to population health. Atherosclerosis. 2020;300:37\u20138.","journal-title":"ATHEROSCLEROSIS"},{"issue":"2","key":"2895_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/dom.13537","volume":"21","author":"GA Nichols","year":"2019","unstructured":"Nichols GA, Philip S, Reynolds K, Granowitz CB, Fazio S. Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol. Diabetes Obes Metab. 2019;21(2):366\u201371.","journal-title":"DIABETES OBES METAB"},{"issue":"1","key":"2895_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","volume":"14","author":"UK Sampson","year":"2012","unstructured":"Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2012;14(1):1\u201310.","journal-title":"CURR ATHEROSCLER REP"},{"issue":"3","key":"2895_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/clc.22692","volume":"40","author":"DL Bhatt","year":"2017","unstructured":"Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif J, Ketchum SB, Doyle RTJ, Murphy SA, Soni PN, et al. Rationale and design of REDUCE-IT: reduction of cardiovascular events with icosapent ethyl-intervention trial. Clin Cardiol. 2017;40(3):138\u201348.","journal-title":"CLIN CARDIOL"},{"issue":"7","key":"2895_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"CLIN BIOCHEM"},{"key":"2895_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2021.03.009","volume":"324","author":"K Won","year":"2021","unstructured":"Won K, Heo R, Park H, Lee BK, Lin FY, Hadamitzky M, Kim Y, Sung JM, Conte E, Andreini D, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46\u201351.","journal-title":"ATHEROSCLEROSIS"},{"key":"2895_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12872-016-0274-7","volume":"16","author":"Y Zhan","year":"2016","unstructured":"Zhan Y, Xu T, Tan X. Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: atherogenic index of plasma, neutrophil-lymphocyte ratio. BMC Cardiovasc Disor. 2016;16:96.","journal-title":"BMC CARDIOVASC DISOR"},{"issue":"1","key":"2895_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13098-023-00992-4","volume":"15","author":"X Wu","year":"2023","unstructured":"Wu X, Gao Y, Wang M, Peng H, Zhang D, Qin B, Pan L, Zhu G. Atherosclerosis indexes and incident T2DM in middle-aged and older adults: evidence from a cohort study. Diabetol Metab Syndr. 2023;15(1):23.","journal-title":"DIABETOL METAB SYNDR"},{"issue":"1","key":"2895_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12902-025-01925-0","volume":"25","author":"L Zhu","year":"2025","unstructured":"Zhu L, Lv T, Song S, Tan Y, She Y, Zhou X, Yu J, Yan Q. Association of atherogenic index of plasma with kidney dysfunction in diabetic individuals: findings from two National population-based studies. BMC Endocr Disord. 2025;25(1):105.","journal-title":"BMC ENDOCR DISORD"},{"issue":"11","key":"2895_CR29","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.6026\/973206300181109","volume":"18","author":"MS Ds","year":"2022","unstructured":"Ds MS, Krishnan DRNA. Atherogenic index of plasma, lipid accumulation and visceral adiposity in metabolic syndrome patients. Bioinformation. 2022;18(11):1109\u201313.","journal-title":"BIOINFORMATION"},{"issue":"1","key":"2895_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12933-025-02903-5","volume":"24","author":"L Wen","year":"2025","unstructured":"Wen L, Wu Y, Fu X, Huo W, Xu A, Piao C, Kong J, Su Y, Liang J, Guo B, et al. Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-year cohort study. Cardiovasc Diabetol. 2025;24(1):349.","journal-title":"CARDIOVASC DIABETOL"},{"key":"2895_CR31","doi-asserted-by":"publisher","first-page":"1150563","DOI":"10.3389\/fpubh.2023.1150563","volume":"11","author":"A Tamosiunas","year":"2023","unstructured":"Tamosiunas A, Luksiene D, Kranciukaite-Butylkiniene D, Radisauskas R, Sopagiene D, Bobak M. Predictive importance of the visceral adiposity index and atherogenic index of plasma of all-cause and cardiovascular disease mortality in middle-aged and elderly Lithuanian population. Front Public Health. 2023;11:1150563.","journal-title":"FRONT PUBLIC HEALTH"},{"issue":"4","key":"2895_CR32","doi-asserted-by":"publisher","first-page":"e70616","DOI":"10.1002\/hsr2.70616","volume":"8","author":"A Salari","year":"2025","unstructured":"Salari A, Kalhor P, Vakili-Basir A, Karvane HB, Pashang M, Ghavami M, Jalali A, Alaeddini F, Masoudkabir F. Atherogenic index of plasma (AIP) as a long-term prognostic factor following CABG: unveiling insights from a large-scale tertiary center registry analysis. Health Sci Rep-US. 2025;8(4):e70616.","journal-title":"HEALTH SCI REP-US"},{"issue":"18","key":"2895_CR33","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.117.027597","volume":"136","author":"M Gaudino","year":"2017","unstructured":"Gaudino M, Antoniades C, Benedetto U, Deb S, Di Franco A, Di Giammarco G, Fremes S, Glineur D, Grau J, He G, et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation. 2017;136(18):1749\u201364.","journal-title":"Circulation"},{"issue":"1","key":"2895_CR34","doi-asserted-by":"publisher","first-page":"13207","DOI":"10.1038\/s41598-017-13267-6","volume":"7","author":"W Ni","year":"2017","unstructured":"Ni W, Zhou Z, Liu T, Wang H, Deng J, Liu X, Xing G. Gender-and lesion number-dependent difference in atherogenic index of plasma in Chinese people with coronary heart disease. Sci Rep-UK. 2017;7(1):13207.","journal-title":"SCI REP-UK"},{"issue":"1","key":"2895_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12944-019-1043-2","volume":"18","author":"G Cai","year":"2019","unstructured":"Cai G, Liu W, Lv S, Wang X, Guo Y, Yan Z, Du Y, Zhou Y. Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study. Lipids Health Dis. 2019;18(1):99.","journal-title":"LIPIDS HEALTH DIS"},{"issue":"18","key":"2895_CR36","doi-asserted-by":"publisher","first-page":"e1051","DOI":"10.4244\/EIJ-D-24-00992","volume":"21","author":"DS Castiello","year":"2025","unstructured":"Castiello DS, Oliva A, And\u00f2 G, Niccoli G, Pelliccia F, Moscarella E, Montone RA, Gragnano F, Porto I, Calabr\u00f2 P, et al. Antithrombotic therapy in complex percutaneous coronary intervention. Eurointervention. 2025;21(18):e1051\u201368.","journal-title":"EUROINTERVENTION"},{"issue":"1","key":"2895_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12933-023-02022-z","volume":"22","author":"O De Filippo","year":"2023","unstructured":"De Filippo O, D\u2019Ascenzo F, Iannaccone M, Bertaina M, Leone A, Borzillo I, Ravetti E, Solano A, Pagliassotto I, Nebiolo M, et al. Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials. Cardiovasc Diabetol. 2023;22(1):324.","journal-title":"CARDIOVASC DIABETOL"},{"issue":"11","key":"2895_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jcin.2025.04.044","volume":"18","author":"FG Biccir\u00e8","year":"2025","unstructured":"Biccir\u00e8 FG, Fabbiocchi F, Gatto L, La Manna A, Ozaki Y, Romagnoli E, Marco V, Boi A, Fineschi M, Piedimonte G, et al. Long-Term prognostic impact of OCT-Derived High-Risk plaque features: extended Follow-Up of the CLIMA study. JACC-Cardiovasc Inte. 2025;18(11):1361\u201372.","journal-title":"JACC-CARDIOVASC INTE"},{"issue":"13","key":"2895_CR39","doi-asserted-by":"publisher","first-page":"e1099","DOI":"10.4244\/EIJ-D-22-00306","volume":"18","author":"E Fabris","year":"2023","unstructured":"Fabris E, Berta B, Hommels T, Roleder T, Hermanides RS, Rivero F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, et al. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma. Eurointervention. 2023;18(13):e1099\u2013107.","journal-title":"EUROINTERVENTION"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02895-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02895-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02895-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:03:41Z","timestamp":1778457821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02895-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2895"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02895-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}